Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose ...

Drugmaker AbbVie Inc raised its full-year profit forecast on Friday, bolstered by signs of recovery in demand for its Botox injection on easing COVID-19 restrictions and strong growth for its latest ...

That’s why we need Senate Bill 41, authored by Sen. Scott Wiener, D-San Francisco, which will require a more fair and ...

Rheumatoid Arthritis Treatment Market Boosted by Biologic Advances and Rising Disease Awareness Rheumatoid arthritis ...

AbbVie (ABBV) stands out after its Allergan acquisition thanks to a transformed portfolio and higher long-term growth ...

The rheumatoid arthritis therapeutics market is set for growth driven by innovative biosimilars like Cyltezo and Hyrimoz, approved for multiple inflammatory conditions. The demand for targeted ...

These three dividend stocks offer different paths to steady income and long-term wealth creation. AbbVie provides growth with ...

A Colorado panel voted Friday to cap the price for a best-selling drug from Amgen. It is one of four states that have passed legislation allowing price caps for specific prescriptions.

Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 1:58 PM EDTCompany ParticipantsMatthew Gline - ...

Any scrapping or even undercutting of the PBS, on which the Australian government spent nearly $18 billion last year to ...

AbbVie has struck deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.

Bank of America Global Healthcare Conference 2025 September 23, 2025 4:50 AM EDTCompany ParticipantsPaul Hudson - CEO ...